Thrivent Financial for Lutherans’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$99M Sell
787,299
-91,516
-10% -$11.5M 0.22% 106
2025
Q1
$97.2M Buy
878,815
+141,043
+19% +$15.6M 0.21% 108
2024
Q4
$101M Buy
737,772
+711,970
+2,759% +$97.2M 0.2% 124
2024
Q3
$2.97M Sell
25,802
-20,775
-45% -$2.39M 0.01% 1189
2024
Q2
$6.41M Buy
46,577
+21,641
+87% +$2.98M 0.01% 803
2024
Q1
$3.44M Buy
24,936
+391
+2% +$53.9K 0.01% 1059
2023
Q4
$3.23M Buy
24,545
+94
+0.4% +$12.4K 0.01% 1052
2023
Q3
$2.75M Sell
24,451
-734
-3% -$82.6K 0.01% 1079
2023
Q2
$2.38M Sell
25,185
-305
-1% -$28.8K 0.01% 1238
2023
Q1
$2.58M Sell
25,490
-4,782
-16% -$484K 0.01% 1127
2022
Q4
$3.62M Buy
30,272
+4,959
+20% +$592K 0.01% 917
2022
Q3
$2.69M Buy
25,313
+238
+0.9% +$25.3K 0.01% 1052
2022
Q2
$2.44M Buy
25,075
+285
+1% +$27.8K 0.01% 1119
2022
Q1
$2.32M Sell
24,790
-224
-0.9% -$21K ﹤0.01% 1230
2021
Q4
$2.13M Buy
25,014
+275
+1% +$23.4K ﹤0.01% 1356
2021
Q3
$2.37M Sell
24,739
-360
-1% -$34.5K ﹤0.01% 1243
2021
Q2
$2.44M Buy
25,099
+124
+0.5% +$12.1K 0.01% 1286
2021
Q1
$2.43M Buy
+24,975
New +$2.43M 0.01% 1298
2020
Q4
Sell
-35,625
Closed -$3.43M 2493
2020
Q3
$3.43M Sell
35,625
-192,400
-84% -$18.5M 0.01% 914
2020
Q2
$27.8M Buy
228,025
+1,075
+0.5% +$131K 0.08% 280
2020
Q1
$19.6M Sell
226,950
-49
-0% -$4.24K 0.07% 318
2019
Q4
$24.4M Buy
226,999
+20,464
+10% +$2.2M 0.07% 324
2019
Q3
$18.6M Buy
206,535
+6,176
+3% +$557K 0.06% 342
2019
Q2
$16.9M Buy
200,359
+14,752
+8% +$1.25M 0.05% 374
2019
Q1
$16.4M Sell
185,607
-506,244
-73% -$44.6M 0.05% 361
2018
Q4
$49.4M Buy
691,851
+336,101
+94% +$24M 0.18% 148
2018
Q3
$43.7M Buy
355,750
+101,517
+40% +$12.5M 0.14% 181
2018
Q2
$25M Buy
254,233
+2,834
+1% +$278K 0.08% 256
2018
Q1
$20.8M Sell
251,399
-364
-0.1% -$30.2K 0.07% 277
2017
Q4
$19.5M Sell
251,763
-830
-0.3% -$64.4K 0.07% 284
2017
Q3
$15.5M Hold
252,593
0.05% 313
2017
Q2
$11.6M Hold
252,593
0.05% 362
2017
Q1
$10.9M Hold
252,593
0.05% 363
2016
Q4
$9.78M Sell
252,593
-760
-0.3% -$29.4K 0.04% 394
2016
Q3
$12.8M Buy
253,353
+4,600
+2% +$233K 0.06% 316
2016
Q2
$11.3M Hold
248,753
0.05% 338
2016
Q1
$9.84M Buy
248,753
+2,940
+1% +$116K 0.05% 364
2015
Q4
$13.9M Sell
245,813
-35,530
-13% -$2.01M 0.07% 270
2015
Q3
$11.2M Buy
281,343
+52,520
+23% +$2.09M 0.06% 310
2015
Q2
$10.9M Buy
228,823
+4,400
+2% +$210K 0.06% 310
2015
Q1
$8.91M Sell
224,423
-420,990
-65% -$16.7M 0.05% 362
2014
Q4
$14.4M Sell
645,413
-10,650
-2% -$238K 0.08% 260
2014
Q3
$10.3M Sell
656,063
-15,500
-2% -$243K 0.06% 307
2014
Q2
$9.96M Sell
671,563
-427
-0.1% -$6.34K 0.06% 329
2014
Q1
$10.8M Buy
671,990
+223,050
+50% +$3.59M 0.07% 287
2013
Q4
$4.19M Buy
448,940
+109,050
+32% +$1.02M 0.03% 470
2013
Q3
$3.85M Sell
339,890
-7,010
-2% -$79.4K 0.02% 478
2013
Q2
$4.64K Buy
+346,900
New +$4.64K 0.03% 439